Dr Megan Smyth – Future Leaders program
Almac Sciences is delighted to announce Dr. Megan Smyth, Team Leader, Custom & Flow Chemistry, has been awarded a highly competitive UK Research and Innovation (UKRI) Future Leaders Fellowship (FLF). The Research and Development grant, worth £1.5 million, enables further enhancement of innovative continuous manufacturing in tandem with a strong focus on development of strategic leadership thus strengthening the business skills for the Fellow.
The FLF scheme facilitates the development of the next wave of world-class research and innovation leaders for both academia and business. The FLF scheme also supports the Fellows through their ambitious and challenging projects in conjunction with the host organization.
Dr. Megan Smyth commented: “Using flow technology opens up many opportunities to replace traditional stoichiometric oxidants with inexpensive, green and abundant oxygen. Through this grant, my team and I will exploit innovative approaches such as ultrafine bubbles and 3D printing to streamline chemical processing resulting in cost savings for our customers. This oxidative platform will allow us to back integrate raw material synthesis into our manufacturing assets in the UK and Ireland resulting in more secure supply chains.”
Watch the full video below.View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.